Regen BioPharma Inc (RGBP)

[cvinvestor]

Several factors lead me to believe this was not an anticipated event:

1. The fact they hired a new President less than a month ago to begin Nov 15th, but had to change that hiring to Oct 31st upon resignation of T. Ichim

2. The fact the T. Ichim was recently announced as SAB I believe to another bio tech company

3. T. Ichim had a 3 year contract with RGBP with incentive shares


My guess is that T. Ichim was stretching himself too thin (Others have pointed out that his name appears associated with a variety of companies) and that he may have had a heart attack or mild stroke and is in a situation where doctors have told him unequivocally that he needs to rest/slow down and cannot continue daily work for a while.

I believe this was sudden and that is why contracts had to been altered to cover his resignation with a new contract for Landers. I don't think this has anything to do with C. Ichim who I believe has been leading the NR2F6 research.

Certainly, this is an unexpected and sad event for the company in some ways, but I do not believe it is a catastrophic event and the fact that T. Ichim is not severing ties with the company, but is on contractual pay means that as his health allows, he will continue to help forward the research.

I don't see any evidence that this is anything other than a sudden health event that is putting him on rest for the time being.

AIMO